Previous 10 | Next 10 |
An update on the 20 life sciences companies Numenor Capital has profiled so far range from cell therapy companies like SQZ Biotech and Orchard Therapeutics to biologics platforms like Pandion. The best performing investment, over 170% return, so far has been Pandion Therapeutics that ...
Gainers: [[SEAC]] +30.3%. [[ABCL]] +13.7%. [[VSTM]] +9.7%. [[GIII]] +9.5%. [[RRR]] +8.8%.Losers: [[WVE]] -24.8%. [[SCPH]] -15.4%. [[PCVX]] -12%. [[UPC]] -9.5%. [[TDUP]] -6%. For further details see: VSTM, WVE, ABCL and SCPH among after-hours movers
The European Medicine Agency's Committee for Medicinal Products ("CHMP") for Human Use has issued a positive opinion for Verastem's (VSTM) Copiktra (duvelisib) for the treatment of relapsed/refractory chronic lymphocytic leukemia (CLL) and refractory follicular lymphoma.In trials, Copiktra wa...
Verastem (VSTM): Q4 Non-GAAP EPS of -$0.09 in-line; GAAP EPS of -$0.12.Revenue of $0.51M (-85.9% Y/Y) misses by $1.09M.Strong balance sheet with cash, equivalents and investments totaling $147.2 Million, expected to have cash runway until at least 2024.Shares +0.42%.Press Release For furthe...
Two Phase 2, Registration-Directed Trials Underway in High Unmet Need Indications with Multiple Key Catalysts Expected in 1H 2022 RAMP 201 Low-Grade Serous Ovarian Cancer Trial Expanded to Now Include Patients with KRAS Wild-Type Tumors in Selection Phase Based on New Clinical...
Verastem, Inc. (Nasdaq:VSTM) (also known as Verastem Oncology), a biopharmaceutical company committed to advancing new medicines for patients battling cancer, today announced that the Company will participate in the virtual H.C. Wainwright Global Life Sciences Conference. The fireside c...
Shares of Verastem (VSTM) closed up 7.1% to $2.57.An abstract poster was presented today at the RAS-Targeted Drug Discovery Summit on its RAF/MEK inhibitor VS-6766.The poster was on synergistic combinations using VS-6766 establishing the candidate as the "backbone of therapy for RAS...
5 Biotech Penny Stocks Trending This Week In the past twelve months, biotech penny stocks have become all the rage. Regardless of whether they are working on a covid treatment, investors have shown a massive propensity for penny stocks in the biotechnology industry. The term biotech...
Gainers: [[EH]] +18.6%. [[VSTM]] +17.7%. [[CSOD]] +11.4%. [[SSP]] +10.93%. [[MREO]] +10.6%.Losers: [[MVIS]] -10.4%. [[EPSN]] -7.5%. [[BLCT]] -4.7%. [[DRVN]] -3.7%. [[FELE]] -3.4%. For further details see: EH, CSOD, MVIS and DRVN among after-hours movers
In its just-released 13F filing, the biotech-focused investment outfit discloses a 10.14M share stake in Verastem (VSTM).Shares are up 24.2% in after hours action. For further details see: Verastem up 24% after Baker Brothers reports stake
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
24.23%Change Percent:
Verastem Inc. Company Name:
VSTM Stock Symbol:
NASDAQ Market:
Verastem Inc. Website:
A look at the top 10 most actives in the United States Sangamo Therapeutics Inc. (SGMO) rose 50.7% to $0.604699 on volume of 90,844,210 shares Selina Hospitality PLC (SLNA) rose 7.7% to $0.028 on volume of 57,431,570 shares NuZee Inc. (NUZE) rose 260.1% to $3.7094 on volume of 53,639,595 ...
Verastem Oncology, (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced the pricing of an underwritten public offering of 13,333,334 shares of its common stock and accompanying warrants to purchase up to 13,333,334 shares of it...
Verastem Oncology, (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced that it intends to offer and sell shares of its common stock and accompanying warrants to purchase shares of common stock, as well as pre-funded warrants t...